eJIFCC Volume 16 no 2 - 2005
|1||The 4th FESCC Continuous Postgraduate Course in Clinical Chemistry: New trends in diagnosis monitoring and management of tumour diseases|
|2||Basic concepts of cancer: Genomic determination|
|3||Interaction between cell death and cell proliferation in cancer|
Tihana Žanic Grubišic
|4||Global approach to biomedicine: Functional genomics and proteomics|
Kresimir Pavelic, Marijeta Kralj, Sandra Kraljevic, Mirela Sedic
|5||Biology of metastasis with focus on proteases|
|6||The potential of cancer screening programmes in Europe|
|7||Cancer and environment|
|8||Tumour markers: Rationale use|
Mathias M. Müller, Marietta Vogl
|9||Laboratory diagnosis and monitoring of leukaemias and lymphomas at molecular level|
|10||Breast cancer and HER-2/neu|
|11||PSA and other biomarkers for early detection diagnosis and monitoring of prostate cancer|
Michel Langlois, Victor Blaton
Michael Neumaier, Stefanie Nittka
|13||Pharmacogenetic and tumour drugs|
|14||Towards automation for molecular diagnosis of cancer|
Maurizio Ferrari, Paola Carrera
|15||Ethics and quality assessment in genetic testing|
|16||Proteomics: A study of therapy resistance in cancer cells|
|17||Detection of disseminated cancer cells in blood|
Albert W.H., Hauch S., Zieglschmid V., Böcher O.
|18||Gene expression profiles - What the clinician needs to know|
Copyright © 2005 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).
All rights reserved.
Contents may not be reproduced without the prior permission of the Communications and Publications Division (CPD) of the IFCC.